Variability in Radiotherapy Outcomes Across Cancer Types: A Comparative Study of Glioblastoma Multiforme and Low-Grade Gliomas
Preprint
Abstract
Radiotherapy is a crucial treatment option for various cancers. However, the results of radiotherapy can vary widely across different cancer types and even among patients with the same type of cancer. This variability presents a major challenge in optimizing treatment strategies and improving patient survival. Here, we collected radiotherapy phenotype and expression data from 32 TCGA cancer datasets and performed overall survival analysis for 32 cancer types. Additionally, we conducted a signalling pathway enrichment analysis to identify key pathways involved in radiotherapy resistance and sensitivity. Our findings show that radiotherapy improves survival outcomes in certain cancer types, such as GBM, while worsening outcomes in others, such as LGG. Next, we focused on exploring the differences in radiotherapy outcomes between GBM and LGG, focusing on the molecular mechanisms contributing to these variations. The differential regulation of pathways related to programmed cell death, DNA repair, telomere maintenance, chromosome condensation, antiviral responses, and interferon signaling between GBM and LGG patients may elucidate the underlying reasons for these observed differences. These insights underscore the importance of personalized treatment approaches and the need for further research to improve radiotherapy outcomes in cancer patients.Keywords
All Related Versions
- Published version: Aging, null (2), 550.
This publication has 22 references indexed in Scilit:
- PandaOmics: An AI-Driven Platform for Therapeutic Target and Biomarker DiscoveryJournal of Chemical Information and Modeling, 2024
- Development and validation of an immune-related gene signature for predicting the radiosensitivity of lower-grade gliomasScientific Reports, 2022
- Radiotherapy for glioblastoma: clinical issues and nanotechnology strategiesBiomaterials Science, 2021
- The Association Between Radiation Therapy Dose and Overall Survival in Patients With Intracranial Infiltrative Low-Grade Glioma Treated With Concurrent and/or Adjuvant ChemotherapyAdvances in Radiation Oncology, 2021
- Combining Radiation Therapy With Interferons: Back to the FutureInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2020
- Visualizing and interpreting cancer genomics data via the Xena platformNature Biotechnology, 2020
- Novel Therapies for GlioblastomaCurrent Neurology and Neuroscience Reports, 2020
- Molecular Pathogenesis of Low-Grade GliomaNeurosurgery Clinics of North America, 2019
- The role of radiation in treating glioblastoma: here to stayJournal of Neuro-Oncology, 2017
- Encouraging experience of concomitant Temozolomide with radiotherapy followed by adjuvant Temozolomide in newly diagnosed glioblastoma multiforme: single institution experienceBritish Journal Of Neurosurgery, 2007